|
Bieżący numer
Archiwum
Filmy
Artykuły w druku
O czasopiśmie
Suplementy
Rada naukowa
Recenzenci
Bazy indeksacyjne
Prenumerata
Kontakt
Zasady publikacji prac
Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
|
3/2021
vol. 123 streszczenie artykułu:
Artykuł przeglądowy
Mycotic corneal ulcers caused by Fusarium spp.- available therapeutic options
Ewelina Trojacka
1
,
Justyna Izdebska
1, 2
,
Marta Wroblewska
3, 4
,
Beata Sulik-Tyszka
3, 4
,
Karolina Ciepiaszuk
1, 2
,
Jacek P. Szaflik
1
1.
Independent Public Clinical Ophthalmology Hospital in Warsaw, Poland
2.
Chair and Department of Ophthalmology, II Faculty of Medicine, Medical University of Warsaw, Poland
3.
Department of Microbiology of the Central Clinical Hospital, University Clinical Center of the Medical University of Warsaw, Poland
4.
Department of Dental Microbiology, Medical University of Warsaw, Poland
KLINIKA OCZNA 2021, 123, 3: 108–113
Data publikacji online: 2021/10/13
Pełna treść artykułu
Pobierz cytowanie
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Fungal corneal ulcers caused by Fusarium spp. are known as sight threatening infection with bad course. Fungus properties, diagnostic difficulties and limited therapeutic ways result in poor outcomes. Three of antimycotic drugs are effective against Fusarium spp.: natamycin, amphotericin B and voriconazole. Natamycin is the only drug approved by FDA (Food and Drug Administration) for treatment of corneal ulcers caused by Fusarium spp. Fungistatic work and limited ocular penetration of antimycotic drugs lead to therapeutic keratoplasty in cases with extremely bad course. Patient with recurrent infections and very advanced inflammation, require enucleation. |
|
ENGLISH
